at Investor's Business Daily (Jan 8, 2015)
A host of Wall Street firms weigh in on NuVasive (NUVA -34%), cutting their ratings after the...
A host of Wall Street firms weigh in on NuVasive (NUVA -34%), cutting their ratings after the company lowered its Q3 revenue outlook late yesterday. Barclay's downgrades the shares to Equalweight, JMP to Market Perform, First Analysis to Equal Weight, Summer Street to Neutral, BMO and RBC to Underperform, and Well Fargo to Market Perform. Wells also also hacked it's price target range on the shares to $15 - $16 from $29 - $31.
From other sites
at Zacks.com (Nov 14, 2014)
at Zacks.com (Nov 5, 2014)
at MarketWatch.com (Oct 4, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs